Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (α-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): A pilot study

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 931-936

  Toma, Salvatore ^a,d   Ragni, Nicola ^a   Raffo, Patrizia ^a   Boselli, Fausto ^b   Gustavino, Claudio ^a   Rugiati, Sergio ^c   Formelli, Franco ^a   Palumbo, Raffaella ^a   Rosso, Riccardo ^a   De Cecco, Luigi ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c San Paolo Hospital   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Interferon 2a; 13 cis retinoic acid; Cervical intraepithelial neoplasia

Indexed keywords

ALPHA2A INTERFERON; CYTOKINE; ISOTRETINOIN; RETINOID;

ADULT; ALOPECIA; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INFLUENZA; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REMISSION; SKIN TOXICITY; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; WEIGHT REDUCTION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; INTERFERON ALFA-2A; ISOTRETINOIN; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 8944247268     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Sidney H., Mage G and Bruhat MA: Preinvasive lesions and their treatment. Rev Prat 40 (1): 12-18, 1990.
2. Andersen ES, Merete Hurst: Cryosurgery for cervical intraepithelial neoplasia: 10 years follow-up. Gynecol Oncol 45: 240-242, 1992.
3. 2 laser conization and the loop electrosurgical excision procedure. Obstet Gynecol 79 (1): 147-152, 1992.
4. Ponten J, Adami HO, Bergstrom R et al: Strategies for global control of cervical cancer. Int J Cancer 60: 1-26, 1995.
5. Cinel A, Wittenberg L and Minucci D: Beta-interferon topical treatment in low and high risk cervical lesions. Clin Exp Obstet Gynecol 18 (2): 91-97, 1991.
6. Dunham AM, McCartney JC, McCance DJ et al: Effect of perilesional injection of alpha-interferon on cervical intraepithelial neoplasia and associated human papillomavirus infection. J R Soc Med 83 (8): 490-492, 1990.
7. Iwasaka T, Hayashi Y, Yokoyama M et al. Interferon gamma treatment for cervical intraepithelial neoplasia. Gynecol Oncol 37: 96-102, 1990.
8. Graham V, Surwit ES, Weiner S et al: Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap. West J Med 145: 92-195, 1986.
9. Lippman SM and Meyskens FL Jr: Vitamin A derivatives in the prevention and treatment of human cancer. J Am Coll Nutr 7 (4): 269-284, 1988.
10. Weiner SA, Surwit EA, Graham VE et al: A phase I trial of topically applied trans-retinoic acid in cervical dysplasia: clinical efficacy. Invest New Drugs 4: 241-244, 1986.
11. Meyskens FL, Surwit E, Moon TE et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 86 (7): 539-543, 1994.
12. Frey JR, Peck R and Bollag W: Antiproliferative activity of retinoids, interferon-a and their combination in five human transformed cell lines. Cancer Lett 57: 223-227, 1991.
13. Hemmi H and Breitman TR: Combinations of recombinant human interferons and retinoic acid synergistically induced differentiation of the human leukemia cell line HL-60. Blood 69: 501-507, 1987.
14. Peck R and Bollag W: Potentiation of retinoid-induced differentiation of HL-60 and U937 cell lines by citokines. Eur J Cancer 27: 53-57, 1991.
15. Toma S, Manteghirfo S, Tasso P et al. Antiproliferative and synergistic effect of interferon alpha-2a, retinoids and their association in established human cancer cell lines. Cancer Lett 82: 209-216, 1994.
16. Lippman SM, Kavanagh JJ, Paredes-Espinoza M et al: 13-cis-Retinoic Acid plus Interferon a-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84: 241-245, 1992.
17. Lippman SM, Parkinson DR, Itri LM et al: 13cRA and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 84: 235-241, 1992.
18. Toma S, Palumbo R, Vincenti M et al: Efficacy of recombinant alpha-interferon 2a and 13-cis-retinoic acid in the treatment of squamous cell carcinoma. Ann Oncol 5: 463-465, 1994.
19. Sporn MB and Roberts AB: Cervical dysplasia regression induced by all-trans-retinoic acid (Editorial). J Natl Cancer Inst 86 (7): 476-477, 1994.
20. Toma S, Vincenti M, Palumbo R, Muzio G et al. Results of the association of intralesional recombinant alpha-interferon-2a (α-IFN) plus 13-cis-retinoic acid (13cRA) in the treatment of basal cell carcinomas (BCC) of the skin. Int J Oncol. 3: 1149-1154, 1993.
21. Slaughter DP, Southwick HW and Smejkal W: ́Field cancerizatioń in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 6: 963-968, 1953.